Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
Vaccine Information Statements
|
Vaccine Index
|
Pneumococcal conjugate (PCV13) VIS

Vaccine Information Statements

Pneumococcal conjugate (PCV13) VIS

Pneumococcal conjugate (PCV13) VIS
April 16, 2010
Febrile Seizures Associated with TIV and PCV13
CDC note to healthcare providers
 

Up-to-date translation

You are encouraged to distribute the up-to-date English-language version at the same time as the translation.
Arabic Karen Thai
Chinese Russian Turkish
Hmong Somali Vietnamese
Indonesian Spanish
Pneumococcal conjugate VIS
Adobe Reader®
|
PDF Help
 

Out-of-date translations

The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current English-language version of the following VISs.
TRANSLATIONS OF THE SEPTEMBER 30, 2002 PCV7 VIS
Arabic Hindi Portuguese Tagalog
Armenian Hmong Punjabi Turkish
Bosnian/Croatian/Serbian    Italian Romanian Vietnamese
Chinese Japanese Russian
Farsi Karen Samoan  
Haitian Creole Korean Somali  
These translations do not contain the following CDC update:
spacer
The CDC posted an updated interim PCV VIS. The main reason is to incorporate recent changes in recommendations for 2-4 year olds, but there are other changes throughout as well. There are no changes in contraindications or adverse events, but to prevent parents from getting confused about the differences in indications (especially when the vaccine is administered to 2-4 year olds) it would be best for providers to start using the new version right away. Existing stocks CAN still be used temporarily if immediately switching to the new version is a problem.
TRANSLATIONS OF THE JULY 9, 2001 PCV7 VIS
Cambodian
Laotian
These translations do not contain the following CDC updates:
spacer
Information on the projected 3-year duration of protection has been deleted (it's likely much longer)
spacer
An upper age limit "under 5 years" has been placed on vaccinating children over the age of two years who are at increased risk of serious pneumococcal disease. 
spacer
The website of the Vaccine Adverse Event Reporting System, www.vaers.hhs.gov has been added. 
spacer
A new URL for the National Vaccine Injury Compensation Program www.hrsa.gov/vaccinecompensation has been added.
VACCINE INDEX
Adenovirus Influenza - TIV Polio - IPV
Anthrax Influenza - LAIV Polio - OPV
Chickenpox J. encephalitis Rabies
DTaP MMR Rotavirus
Hib MMRV Shingles
Hepatitis A Meningococcal Smallpox
Hepatitis B Multi-vaccine Td/Tdap
HPV - Cervarix PCV Typhoid
HPV - Gardasil PPSV Yellow fever 
VIS LANGUAGE INDEX
 
How to use VISs
It's Federal Law! You must give your patients current VISs
Explains why it is necessary to always use the most current version of a VIS and lists the current VIS dates
 
Related materials from IAC
Ask the Experts
Handouts
IAC Express
Needle Tips
Vaccinate Adults
Vaccine Policy & Licensing
What's New at IAC
 
GLT
GRT
 
Translate for IAC
If you have a need for a VIS in a language that is not currently offered, please consider translating for IAC yourself and then sharing it with the world via this website!
LEARN MORE
 
GLB
GRB
 
GLT
GRT
 
More from IAC
envelope Subscribe to IAC
Periodicals and email news service - all free!
dollar sign Support IAC
Your support can make a difference!
shopping cart Shop IAC
DVDs, schedules, record cards, and more!
 
GLB
GRB
This page was reviewed on August 31, 2011
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.